Based on literature evidence and expert consensus, the Japanese Classification of Colorectal, Appendiceal, and Anal Carcinoma 1,2) (JCCRC) has been developed and sustained by the Japanese Society for Cancer of the Colon and Rectum (JSCCR) since 1977. Through defining detailed rules for evaluating and documenting clinical and pathological findings, and handling specimens of colorectal cancer, the JCCRC has contributed to the standardization and improvement of the diagnosis and treatment of colorectal cancer in Japan. Furthermore, the JSCCR guidelines for colorectal cancer treatment 3) , which have been revised several times since the first edition was issued in 2005, describe treatment algorithms conforming to the JCCRC; therefore, its importance is continuing to increase. Under these circumstances, the revisions have to maintain the classification's role to further improve treatment outcomes for colorectal cancer in Japan, which are already among the best in the world. At the same time, there is a focus on harmonizing with the eighth edition of the TNM classification 4) and classification of cancers in other organs in Japan.
No takes yet. Share an insight, caveat, or question.
A 2019 study studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: